Continuing Medical Education
Imedex, LLC is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for physicians.
Imedex, LLC designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Who Should Attend
This educational activity is intended for gynecologists, medical oncologists, radiation therapists, surgical oncologists, pathologists, and other practitioners involved in the diagnosis and management of ovarian cancer.
Objectives
Upon completion of this activity, participants should be able to:
- Access the advantages and disadvantages of current and emerging treatment strategies for patients with untreated ovarian cancer
- Discuss the use of novel agents in the maintenance/consolidation setting in terms of patient outcomes
- Summarize the most appropriate treatment algorithm for platinum-resistant ovarian cancer
- Analyze emerging data evaluating the benefits and limitations of using non-platinum or platinum doublets in patients with platinum-sensitive disease
Robert Allen Burger, MD, FACOG, FACS
Fox Chase Center
Philadelphia, Pennsylvania
Robert L. Coleman, MD, FACOG, FACS
M. D. Anderson Cancer Center
Houston, Texas
Bradley J. Monk, MD, FACOG, FACS
University of California Irvine Medical Center
Orange, California
Tate Thigpen, MD
University of Mississippi Medical Center
Jackson, Mississippi
Moderator: Robert L. Coleman, MD, FACOG, FACS
12:00 pm
Registration and lunch
12:30 pm
Welcome and introduction
12:35 pm
Treating the newly diagnosed patient with ovarian cancer: Emerging approaches including maintenance/consolidation strategies
Bradley J. Monk, MD, FACOG, FACS
12:55 pm
How to optimally treat a 5 month platinum-resistant recurrent patient
Robert L. Coleman, MD, FACOG, FACS
1:15 pm
Debate: Management of a platinum-sensitive recurrent patient
Non-platinum doublet perspective: Robert Allen Burger, MD, FACOG, FACS
Platinum doublet perspective: Tate Thigpen, MD
1:45 pm
Panel Discussion on current controversies in recurrent disease
2:00 pm
Conclusion
This is a complimentary educational program to registered attendees of the 2010 SGO Annual Meeting™ and space is limited. To confirm your attendance, please register by Thursday, March 11, 2010.
Moscone West Convention Center
San Francisco, California
Tuesday, March 16, 2010
12:00 pm – 2:00 pm
Rooms 2007/2009
ORGANIZER
Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2008 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following companies have provided an educational grant in support of this symposium:
